|Printable version||E-mail this to a friend|
New Heart Failure Report recommends blood test developed by BHF researchers
The report urges that a simple blood test, costing under £28, should be made available to all hospitals and GPs in England.
Experts say this would speed up diagnosis and save the health service millions of pounds each year.
Saving money and improving lives
The test (NTproBNP) was developed in the late 1990s by BHF researchers at the University of Dundee. It is used to detect levels of natriuretic peptide in a patient’s blood and either rules out or point towards a diagnosis of heart failure.
An economic analysis by the National Institute for Health and Clinical Excellence (NICE) showed that nationally, the net saving resulting from the use of the test in primary care was approximately £3.8 million.
However, despite current recommendations by NICE, the inquiry exposed that access to testing is variable across the country and in some areas, is not commissioned at all.
Living with heart failure can be debilitating, distressing and when untreated it has worse survival rates than some cancers. Over 400,000 people in England have been diagnosed with heart failure and there are likely to be many more undiagnosed cases.
The inquiry, prompted by Westminster’s All-Party Parliamentary Group on Heart Disease (APPG), received evidence from patients, health care professionals, and commissioners. In total ten recommendations were put forward which includes that all patients should receive specialist input to their care to improve outcomes and quality of life.
Simon Gillespie, Chief Executive of the British Heart Foundation, said: “Heart failure is a devastating condition which leaves sufferers constantly short of breath - unable to continue to do the work and activities they once enjoyed.
“Our research has helped to drastically improve heart attack survival rates, meaning 70% of people now survive. However many are left with irreversibly damaged hearts meaning a life sentence of living with debilitating heart failure.
“We urgently need to fund more research into heart failure to find new and better ways to prevent, diagnose and treat this cruel condition. But we must also improve quality of life for those currently suffering with this condition and we are keen to work with the Government and NHS to achieve this.”
Read the full report (PDF)
Latest News from
Cancer Research UK - 1 in 5 emergency bowel cancer patients had symptoms before diagnosis29/09/2016 14:35:00
Around one in five bowel cancer patients diagnosed after an emergency presentation have displayed at least one cancer ‘alarm symptom’ in the year leading up to their diagnosis, according to a Cancer Research UK-funded study (link is external) published in the British Journal of Cancer (link is external).
BHF - Common prescription painkillers linked to increased risk of heart failure29/09/2016 12:35:00
A study has found that commonly used prescribed painkillers, used to treat pain and inflammation, are associated with an increased risk of hospitalisation for heart failure.
Cancer Research UK - Low cancer symptom awareness linked to lower chance of survival29/09/2016 10:35:00
In regions where cancer survival is poorer, people on average have lower awareness of cancer symptoms, according to new findings (link is external) published yesterday in the British Journal of Cancer(link is external)*.
Cancer Research UK - Precision medicine trial first of its kind to show benefit to patients28/09/2016 08:15:00
A clinical trial for types of advanced cancer is the first of its kind to show that precision medicine – or tailoring treatment for individual people – can slow down the time it takes for a tumour to grow back, according to research presented at the Molecular Analysis for Personalised Therapy (MAP) conference(link is external), last week.